This inventor holds 1 USPTO granted patent. Top assignee: Otsuka Pharmaceutical Company, Limited. Active years: 1994.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1994
Title: Keiko Mizuno: Innovator in Monoclonal Antibody Development
Introduction
Keiko Mizuno is a prominent inventor based in Tokushima, Japan. She has made significant contributions to the field of immunology, particularly in the development of monoclonal antibodies. Her work has implications for both research and clinical applications.
Latest Patents
Mizuno holds a patent for a "Human tumor necrosis factor .alpha. specific monoclonal antibody." This patent discloses monoclonal antibodies that exhibit specificity for human TNF-.alpha. These antibodies are useful for immunological purification and for measuring human TNF-.alpha. in immunoassays. She has 1 patent to her name.
Career Highlights
Keiko Mizuno is associated with Otsuka Pharmaceutical Company, Limited, where she has been involved in groundbreaking research. Her work has contributed to advancements in therapeutic applications and diagnostic tools.
Collaborations
Mizuno has collaborated with notable colleagues, including Yasukazu Ohmoto and Tsutomu Nishida. These partnerships have enhanced the scope and impact of her research.
Conclusion
Keiko Mizuno's innovative work in monoclonal antibody development showcases her dedication to advancing medical science. Her contributions continue to influence the field of immunology and improve diagnostic methods.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile